FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paul Armstrong

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
Jeffrey Bakal; eric boersma; Justin A Ezekowitz; Cynthia M Westerhout; Paul W Armstrong
Association of global weather changes with acute coronary syndromes: gaining insights from clinical trials data.
Paul W Armstrong; Hans-Richard Arntz; Erich Bluhmki; Kris Bogaerts; Antonio C Carvalho; Thierry Danays; Claudio Fresco; Anthony H Gershlick; Patrick Goldstein; Stefan Grajek; Sigrun Halvorsen; Kurt Huber; Yves Lambert; John Nanas; Miodrag Ostojic; Anne Regelin; Fernando Rosell Ortiz; Vitaly Sulimov; Frans Van de Werf; Katleen Vandenberghe; Robert C Welsh; Robert Wilcox
Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction.
Jason J Rose; Frans Van de Werf; Harvey D White; Kenneth W Mahaffey; L Kristin Newby; E Magnus Ohman; Paul W Armstrong; Samuel Broderick; Robert M Califf; Karen Chiswell; Robert P Giugliano; Shaun G Goodman; Christopher B Granger; Robert A Harrington; Renato D Lopes
Left bundle branch block in non-ST-segment elevation acute coronary syndromes. Incidence, angiographic characteristics, and clinical outcomes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paul Armstrong (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jeffrey Bakal; eric boersma; Justin A Ezekowitz; Cynthia M Westerhout; Paul W Armstrong
Association of global weather changes with acute coronary syndromes: gaining insights from clinical trials data.
International journal of biometeorology 2013;57(3):401-8.
2013: Paul W Armstrong; Hans-Richard Arntz; Erich Bluhmki; Kris Bogaerts; Antonio C Carvalho; Thierry Danays; Claudio Fresco; Anthony H Gershlick; Patrick Goldstein; Stefan Grajek; Sigrun Halvorsen; Kurt Huber; Yves Lambert; John Nanas; Miodrag Ostojic; Anne Regelin; Fernando Rosell Ortiz; Vitaly Sulimov; Frans Van de Werf; Katleen Vandenberghe; Robert C Welsh; Robert Wilcox
Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction.
The New England journal of medicine 2013;368(15):1379-87.
2013: Jason J Rose; Frans Van de Werf; Harvey D White; Kenneth W Mahaffey; L Kristin Newby; E Magnus Ohman; Paul W Armstrong; Samuel Broderick; Robert M Califf; Karen Chiswell; Robert P Giugliano; Shaun G Goodman; Christopher B Granger; Robert A Harrington; Renato D Lopes
Left bundle branch block in non-ST-segment elevation acute coronary syndromes. Incidence, angiographic characteristics, and clinical outcomes.
Journal of the American College of Cardiology 2013;61(13):1461-3.
2013: Jeffrey T Guptill; John Horton; Stefan James; daniel laskowitz; Paul W Armstrong; Christopher B Granger; Rajendra H Mehta; Renato D Lopes
Stroke after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: timing, characteristics, and clinical outcomes.
Circulation. Cardiovascular interventions 2013;6(2):176-83.
2013: Padma Kaul; Merril L Knudtson; Becky K Leung; Paul W Armstrong; Justin A Ezekowitz; Hude Quan; Anamaria Savu; Robert C Welsh; Finlay A McAlister
Incidence of heart failure and mortality after acute coronary syndromes.
American heart journal 2013;165(3):379-85.e2.
2013: Cynthia M Westerhout; Robert M Califf; Frans Van de Werf; Christopher B Granger; Stefan K James; Kenneth W Mahaffey; Karen S Pieper; Paul W Armstrong
Dynamic modeling of 90-day mortality in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
American heart journal 2013;165(3):354-62.e2.
2013: Sergio Leonardi; E Magnus Ohman; Phillip J Schulte; Paul W Armstrong; L Kristin Newby
Implementation of standardized assessment and reporting of myocardial infarction in contemporary randomized controlled trials: a systematic review.
European heart journal 2013;34(12):894-902d.
2013: Jeffrey Bakal; Warren J Cantor; Francisco Fernández-Avilés; David Fitchett; Shaun G Goodman; Robert C Welsh; Cynthia M Westerhout; Paul W Armstrong
Evaluation of early percutaneous coronary intervention vs. standard therapy after fibrinolysis for ST-segment elevation myocardial infarction: contribution of weighting the composite endpoint.
European heart journal 2013;34(12):903-8.
2013: Paul W Armstrong; Cynthia M Westerhout
The power of more than one.
Circulation 2013;127(6):665-7.
2013: Manesh R Patel; Hany Siha; Cynthia M Westerhout; Sorin J Brener; Yuling Fu; Christopher B Granger; Raymond J Kim; Paul W Armstrong
Aborted myocardial infarction after primary percutaneous coronary intervention: magnetic resonance imaging insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
American heart journal 2013;165(2):226-33.
2012: Sergio Leonardi; Renato D Lopes; Elliott M Antman; Paul W Armstrong; Robert M Califf; Robert P Giugliano; Megan L Neely; L Kristin Newby; Laine Thomas; Pierluigi Tricoci; Harvey D White; Kenneth W Mahaffey
Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.
Journal of the American College of Cardiology 2012;60(22):2296-304.
2012: Padma Kaul; Cynthia M Westerhout; Yuling Fu; Christopher B Granger; Paul W Armstrong
Relative prognostic value of baseline Q wave and time from symptom onset among men and women with ST-elevation myocardial infarction undergoing percutaneous coronary intervention.
The American journal of cardiology 2012;110(11):1555-60.
2012: Justin A Ezekowitz; Adrian F Hernandez; Jia Hu; Padma Kaul; Rolland Leader; Christopher O'Connor; Guy Proulx; Sean Virani; Cynthia M Westerhout; Michel White; Shelley Zieroth; Diego Delgado; Paul W Armstrong
Acute heart failure: perspectives from a randomized trial and a simultaneous registry.
Circulation. Heart failure 2012;5(6):735-41.
2012: G Michael Felker; Gregg C Fonarow; Vic Hasselblad; Gretchen M Heizer; Adrian F Hernandez; Barry M Massie; John J V McMurray; Marco Metra; Stefan D Anker; Paul W Armstrong; Dan Atar; Javed Butler; Robert M Califf; Kenneth Dickstein; Randall C Starling; W H Wilson Tang; Richard W Troughton; Adriaan A Voors; Christopher M O'Connor
Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study.
European journal of heart failure 2012;14(11):1257-64.
2012: Paul W Armstrong; Robert A Harrington
Road mapping ATLAS ACS 2: are we there yet?
European heart journal 2012;33(20):2510-2.
2012: Adriano A M Truffa; Kyle R White; Hussein R Al-Khalidi; Paul W Armstrong; Christopher B Granger; Judith S Hochman; Rajendra H Mehta; L Kristin Newby; Manesh R Patel; Karen S Pieper; Renato D Lopes
Serious infection after acute myocardial infarction: incidence, clinical features, and outcomes.
JACC. Cardiovascular interventions 2012;5(7):769-76.
2012: Catherine Martel; Amanda Stebbins; Paul W Armstrong; Arnaud Bonnefoy; Annik Fortier; Marta Ghitescu; Christopher B Granger; Pierre Theroux
Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
American heart journal 2012;164(1):43-51.
2012: Robert C Welsh; Paul W Armstrong
Contemporary pharmacological reperfusion in ST elevation myocardial infarction.
Current opinion in cardiology 2012;27(4):340-6.
2012: Sean van Diepen; Arnoud W J van't Hof; W Douglas Weaver; Kyle R White; Petr Widimsky; Diego Ardissino; Paul W Armstrong; Renato D Lopes; Frans Van de Werf; Christopher B Granger
Transfer times and outcomes in patients with ST-segment-elevation myocardial infarction undergoing interhospital transfer for primary percutaneous coronary intervention: APEX-AMI insights.
Circulation. Cardiovascular quality and outcomes 2012;5(4):437-44.
2012: Robert C Welsh; Cynthia M Westerhout; Christopher E Buller; Phillip Gordon; Blair O'Neill; Paul W Armstrong
Anticoagulation after subcutaneous enoxaparin is time sensitive in STEMI patients treated with tenecteplase.
Journal of thrombosis and thrombolysis 2012;34(1):126-31.
2012: Sean van Diepen; Paul W Armstrong; Justin A Ezekowitz; Christian W Hamm; Judith S Hochman; Stefan James; Renato D Lopes; Kenneth W Mahaffey; David J Moliterno; Franz-Josef Neumann; L Kristin Newby; Matthew T Roe; Amanda L Stebbins; Pierre Theroux; Christopher B Granger
Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.
Journal of thrombosis and thrombolysis 2012;34(1):106-13.
2012: Rajendra H Mehta; Manesh R Patel; Karen S Pieper; Robert C Welsh; Yinggan Zheng; Paul W Armstrong; Padma Kaul; Renato D Lopes; Christopher B Granger
Variations in practice and outcomes in patients undergoing primary percutaneous coronary intervention in the United States and Canada: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI) trial.
American heart journal 2012;163(5):797-803.
2012: Mustafa Toma; Samip Vasaiwala; Venkatesan Vidi; Finlay A McAlister; Paul W Armstrong; Jeffrey Bakal; Erin E Coglianese; Justin A Ezekowitz
Testosterone supplementation in heart failure: a meta-analysis.
Circulation. Heart failure 2012;5(3):315-21.
2012: Justin A Ezekowitz; Adrian F Hernandez; John J V McMurray; Christopher M O'Connor; Guy Proulx; Randall C Starling; Mason H Weiss; Jeffrey Bakal; Robert M Califf; Paul W Armstrong
Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow.
Journal of the American College of Cardiology 2012;59(16):1441-8.
2012: Matthew T Roe; Jorge F Saucedo; Pierluigi Tricoci; Frans Van de Werf; Arnoud W van't Hof; Jennifer A White; E Magnus Ohman; Charles V Pollack; Paul W Armstrong; Robert M Califf; Robert P Giugliano; Robert A Harrington; Judith S Hochman; Stefan K James; Padma Kaul; Yuliya Lokhnygina; Chadwick D Miller; Gilles Montalescot; L Kristin Newby
Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS Trial.
Circulation. Cardiovascular quality and outcomes 2012;5(2):205-13.
2012: James S Mills; Jose C Nicolau; Witold Ruzyllo; Thomas G Todaro; Peter X Adams; Paul W Armstrong; Christopher B Granger; Yuliya Lokhnygina; Kenneth W Mahaffey
Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction.
Coronary artery disease 2012;23(2):118-25.
2012: Rajendra H Mehta; Karen S Pieper; Amanda S Stebbins; Eric J Topol; Frans Van de Werf; Harvey D White; John H Alexander; Paul W Armstrong; Robert M Califf; Judith S Hochman; Renato D Lopes; Christopher B Granger
Comparison of incidence of bleeding and mortality of men versus women with ST-elevation myocardial infarction treated with fibrinolysis.
The American journal of cardiology 2012;109(3):320-6.
2012: Paul W Armstrong; Peter Clemmensen; Yuling Fu; Robert A Harrington; Jay Horrow; Stefan K James; Hugo Katus; Hany Siha; Ph Gabriel Steg; Robert F Storey; Cynthia M Westerhout; Lars Wallentin
ST-elevation acute coronary syndromes in the Platelet Inhibition and Patient Outcomes (PLATO) trial: insights from the ECG substudy.
Circulation 2012;125(3):514-21.
2011: Chiara Melloni; Gilles Montalescot; Pierluigi Tricoci; Frans Van de Werf; Jennifer A White; Paul W Armstrong; Robert M Califf; Robert P Giugliano; Robert A Harrington; Kurt Huber; Stefan K James; L Kristin Newby
Safety and efficacy of adjusted-dose eptifibatide in patients with acute coronary syndromes and reduced renal function.
American heart journal 2011;162(5):884-892.e1.
2011: Paul W Armstrong; William E Boden
Reperfusion paradox in ST-segment elevation myocardial infarction.
Annals of internal medicine 2011;155(6):389-91.
2011: Renato D Lopes; Rajendra H Mehta; Manesh R Patel; Hany Siha; Paul W Armstrong; Yuling Fu; Christopher B Granger
Diagnosing acute myocardial infarction in patients with left bundle branch block.
The American journal of cardiology 2011;108(6):782-8.
2011: Wayne Tymchak; Cynthia M Westerhout; Paul W Armstrong; Neil Brass; Yuling Fu; Sunil Sookram; Robert C Welsh
Mode of hospital presentation in patients with non-ST-elevation myocardial infarction: implications for strategic management.
American heart journal 2011;162(3):436-43.
2011: Renato D Lopes; Kenneth W Mahaffey; Helena B Nader; L Kristin Newby; Eric D Peterson; Karen S Pieper; Frans Van de Werf; Lars Wallentin; Harvey D White; John H Alexander; Paul W Armstrong; Richard C Becker; Joyce M A Bizzachi; Robert M Califf; Antonio C Carvalho; Mark Y Chan; Mark Crowther; Roberto R Giraldez; Christopher B Granger; Helio P Guimaraes; Robert A Harrington; Elaine M Hylek; Stefan K James; E Marc Jolicoeur; Renato A K Kalil; Antonio C Lopes; David A Garcia
Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil.
Journal of thrombosis and thrombolysis 2011;32(2):242-66.
2011: Pierluigi Tricoci; Frans Van de Werf; Harvey D White; Paul W Armstrong; Leonardo Bolognese; Eugene Braunwald; Robert M Califf; Eric Durand; Robert P Giugliano; Vic Hasselblad; David F Kong; David J Moliterno; L Kristin Newby; Dorairaj Prabhakaran; Saman Rasoul; Gregg W Stone; Pierre Théroux; Robert A Harrington
Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials.
Circulation. Cardiovascular quality and outcomes 2011;4(4):448-58.
2011: Paul W Armstrong; Cynthia M Westerhout; Frans Van de Werf; Robert M Califf; Robert C Welsh; Robert G Wilcox; Jeffrey Bakal
Refining clinical trial composite outcomes: an application to the Assessment of the Safety and Efficacy of a New Thrombolytic-3 (ASSENT-3) trial.
American heart journal 2011;161(5):848-54.
2011: Rajendra H Mehta; Aijing Z Starr; Renato D Lopes; Jonathan P Piccini; Manesh R Patel; Karen S Pieper; Paul W Armstrong; Christopher B Granger
Relationship of sustained ventricular tachyarrhythmias to outcomes in patients undergoing primary percutaneous coronary intervention with varying underlying baseline risk.
American heart journal 2011;161(4):782-9.
2011: S Michael Gharacholou; Renato D Lopes; Karen P Alexander; Rajendra H Mehta; Amanda L Stebbins; Karen S Pieper; Stefan K James; Paul W Armstrong; Christopher B Granger
Age and outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: findings from the APEX-AMI trial.
Archives of internal medicine 2011;171(6):559-67.
2011: Kenneth W Mahaffey; June L Wampole; Amanda Stebbins; Lisa G Berdan; Donna McAfee; Tyrus L Rorick; John K French; Neal S Kleiman; Christopher M O'Connor; Eric A Cohen; Christopher B Granger; Paul W Armstrong
Strategic lessons from the clinical event classification process for the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
Contemporary clinical trials 2011;32(2):178-87.
2011: Tracy Y Wang; Jennifer A White; Pierluigi Tricoci; Robert P Giugliano; Uwe Zeymer; Robert A Harrington; Gilles Montalescot; Stefan K James; Frans Van de Werf; Paul W Armstrong; Eugene Braunwald; Robert M Califf; L Kristin Newby
Upstream clopidogrel use and the efficacy and safety of early eptifibatide treatment in patients with acute coronary syndrome: an analysis from the Early Glycoprotein IIb/IIIa Inhibition in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial.
Circulation 2011;123(7):722-30.
2011: Padma Kaul; Finlay A McAlister; Justin A Ezekowitz; Jeffrey Bakal; Lesley H Curtis; Hude Quan; Merril L Knudtson; Paul W Armstrong
Resource use in the last 6 months of life among patients with heart failure in Canada.
Archives of internal medicine 2011;171(3):211-7.
2011: Cynthia M Westerhout; Eric Bonnefoy; Robert C Welsh; Philippe Gabriel STEG; Florent Boutitie; Paul W Armstrong
The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: a pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST.
American heart journal 2011;161(2):283-90.
2011: Rajendra H Mehta; J Conor O'Shea; Amanda L Stebbins; Christopher B Granger; Paul W Armstrong; Harvey D White; Eric J Topol; Robert M Califf; E Magnus Ohman
Association of mortality with years of education in patients with ST-segment elevation myocardial infarction treated with fibrinolysis.
Journal of the American College of Cardiology 2011;57(2):138-46.
2011: Rajendra H Mehta; Amanda Stebbins; Renato D Lopes; Sunil V Rao; Eric R Bates; Karen S Pieper; Paul W Armstrong; Frans Van de Werf; Harvey D White; Robert M Califf; John H Alexander; Christopher B Granger
Race, Bleeding, and Outcomes in STEMI Patients Treated with Fibrinolytic Therapy.
The American journal of medicine 2011;124(1):48-57.
2011: Padma Kaul; Paul W Armstrong; Sunil Sookram; Becky K Leung; Neil Brass; Robert C Welsh
Temporal trends in patient and treatment delay among men and women presenting with ST-elevation myocardial infarction.
American heart journal 2011;161(1):91-7.
2010: Mustafa Toma; Yuling Fu; Justin A Ezekowitz; Finlay A McAlister; Cynthia M Westerhout; Christopher B Granger; Paul W Armstrong
Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial.
American heart journal 2010;160(4):671-7.
2010: Amanda L Stebbins; Rajendra H Mehta; Paul W Armstrong; Kerry L Lee; Christian Hamm; Frans Van de Werf; Stefan James; Torsten Toftegaard-Nielsen; Ricardo Seabra-Gomes; Harvey D White; Christopher B Granger
A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial.
Circulation. Cardiovascular interventions 2010;3(5):414-22.
2010: Michael C Tjandrawidjaja; Yuling Fu; Cynthia M Westerhout; Galen S Wagner; Christopher B Granger; Paul W Armstrong
Usefulness of the QRS score as a strong prognostic marker in patients discharged after undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
The American journal of cardiology 2010;106(5):630-4.
2010: Justin A Ezekowitz; Paul W Armstrong; Christopher B Granger; Pierre Theroux; Amanda Stebbins; Raymond J Kim; Manesh R Patel
Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.
American heart journal 2010;160(2):272-8.
2010: Paul W Armstrong; Anthony Gershlick; Patrick Goldstein; Robert Wilcox; Thierry Danays; Erich Bluhmki; Frans Van de Werf
The Strategic Reperfusion Early After Myocardial Infarction (STREAM) study.
American heart journal 2010;160(1):30-35.e1.
2010: Chee Tang Chin; Matthew T Roe; Keith A A Fox; Dorairaj Prabhakaran; Debra A Marshall; Helene Petitjean; Yuliya Lokhnygina; Eileen Brown; Paul W Armstrong; Harvey D White; E Magnus Ohman
Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.
American heart journal 2010;160(1):16-22.e1.
2010: Mustafa Toma; Christopher E Buller; Cynthia M Westerhout; Yuling Fu; William W O'Neill; David R Holmes; Christian W Hamm; Christopher B Granger; Paul W Armstrong
Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.
European heart journal 2010;31(14):1701-7.
2010: Sean van Diepen; Hany Siha; Yuling Fu; Cynthia M Westerhout; Renato D Lopes; Christopher B Granger; Paul W Armstrong
Do baseline atrial electrocardiographic and infarction patterns predict new-onset atrial fibrillation after ST-elevation myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial.
Journal of electrocardiology 2010;43(4):351-8.
2010: E Magnus Ohman; Matthew T Roe; Paul W Armstrong; Keith A Fox; Dorairaj Prabhakaran; Harvey D White
Public sensationalism and clinical trials: how to address the challenges of science?
The American journal of medicine 2010;123(6):481-3.
2010: Osama Alhadramy; Cynthia M Westerhout; Sorin J Brener; Christopher B Granger; Paul W Armstrong
Is visual interpretation of coronary epicardial flow reliable in patients with ST-elevation myocardial infarction undergoing primary angioplasty? Insights from the angiographic substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
American heart journal 2010;159(5):899-904.
2010: Robert C Welsh; Christopher B Granger; Cynthia M Westerhout; James C Blankenship; David R Holmes; William W O'Neill; Christian W Hamm; Frans Van de Werf; Paul W Armstrong
Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
JACC. Cardiovascular interventions 2010;3(3):343-51.
2010: Michael C Tjandrawidjaja; Yuling Fu; Cynthia M Westerhout; Harvey D White; Thomas G Todaro; Frans Van de Werf; Kenneth W Mahaffey; Galen S Wagner; Christopher B Granger; Paul W Armstrong
Resolution of ST-segment depression: A new prognostic marker in ST-segment elevation myocardial infarction.
European heart journal 2010;31(5):573-81.
2010: Renato D Lopes; Aijing Starr; Carl F Pieper; Sana M Al-Khatib; L Kristin Newby; Rajendra H Mehta; Frans Van de Werf; Kenneth W Mahaffey; Paul W Armstrong; Robert A Harrington; Harvey D White; Lars Wallentin; Christopher B Granger
Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes.
The American journal of medicine 2010;123(2):134-40.
2010: Manesh R Patel; Stephen G Worthley; Amanda Stebbins; Thorsten Dill; Frank E Rademakers; Uma S Valeti; Uma S Velleti; Gregory W Barsness; Frans Van de Werf; Christian W Hamm; Paul W Armstrong; Christopher B Granger; Raymond J Kim
Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.
JACC. Cardiovascular imaging 2010;3(1):52-60.
2009: Jeffrey S Berger; Matthew T Roe; C Michael Gibson; Rakhi Kilaru; Cynthia L Green; Laura Melton; James D Blankenship; D Christopher Metzger; Christopher B Granger; Daniel D Gretler; Cindy L Grines; Kurt Huber; Uwe Zeymer; Pawel Buszman; Robert A Harrington; Paul W Armstrong
Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trial.
American heart journal 2009;158(6):998-1004.e1.
2009: Mark E Patterson; William C Grant; Seth Glickman; Barry M Massie; Susan E Ammon; Paul W Armstrong; John G F Cleland; Joseph F Collins; Koon K Teo; Kevin Schulman; Shelby D Reed
Resource use and costs of treatment with anticoagulation and antiplatelet agents: results of the WATCH trial economic evaluation.
Journal of cardiac failure 2009;15(10):819-27.
2009: E Marc Jolicoeur; William W O'Neill; Anne S Hellkamp; Christian W Hamm; David R Holmes; Hussein R Al-Khalidi; Manesh R Patel; Frans J Van de Werf; Karen Pieper; Paul W Armstrong; Christopher B Granger
Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
European heart journal 2009;30(21):2575-83.
2009: Renato D Lopes; Laine E Elliott; Harvey D White; Judith S Hochman; Frans Van de Werf; Diego Ardissino; Torsten T Nielsen; W Douglas Weaver; Petr Widimsky; Paul W Armstrong; Christopher B Granger
Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial.
European heart journal 2009;30(16):2019-28.
2009: Kevin R Bainey; Yuling Fu; Christopher B Granger; C W Hamm; D R Holmes; William W O'Neill; R Seabra-Gomes; M E Pfisterer; Frans Van de Werf; Paul W Armstrong
Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients?
Heart (British Cardiac Society) 2009;95(16):1331-6.
2009: Padma Kaul; C David Naylor; Paul W Armstrong; Daniel B Mark; Pierre Theroux; Gilles R Dagenais
Assessment of activity status and survival according to the Canadian Cardiovascular Society angina classification.
The Canadian journal of cardiology 2009;25(7):e225-31.
2009: Finlay A McAlister; Natasha Wiebe; Justin A Ezekowitz; Alexander A Leung; Paul W Armstrong
Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure.
Annals of internal medicine 2009;150(11):784-94.
2009: Alexander M Clark; C Nicole Freydberg; Finlay A McAlister; Ross T Tsuyuki; Paul W Armstrong; Laurel A Strain
Patient and informal caregivers' knowledge of heart failure: necessary but insufficient for effective self-care.
European journal of heart failure 2009;11(6):617-21.
2009: Rajendra H Mehta; Aijing Z Starr; Renato D Lopes; Judith S Hochman; Petr Widimsky; Karen S Pieper; Paul W Armstrong; Christopher B Granger
Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention.
JAMA : the journal of the American Medical Association 2009;301(17):1779-89.
2009: Paul W Armstrong; Yuling Fu; Cynthia M Westerhout; Michael P Hudson; Kenneth W Mahaffey; Harvey D White; Thomas G Todaro; Peter X Adams; Philip E G Aylward; Christopher B Granger
Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
Journal of the American College of Cardiology 2009;53(17):1503-9.
2009: Tracy Y Wang; Min Zhang; Yuling Fu; Paul W Armstrong; L Kristin Newby; C Michael Gibson; David J Moliterno; Frans Van de Werf; Harvey D White; Robert A Harrington; Matthew T Roe
Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-ST-elevation acute coronary syndromes undergoing diagnostic angiography.
American heart journal 2009;157(4):716-23.
2009: Paul W Armstrong; Cynthia M Westerhout; Robert C Welsh
Duration of symptoms is the key modulator of the choice of reperfusion for ST-elevation myocardial infarction.
Circulation 2009;119(9):1293-303.
2009: Adrian F Hernandez; Christopher M O'Connor; Randall C Starling; Craig J Reist; Paul W Armstrong; Kenneth Dickstein; Todd J Lorenz; W Brian Gibler; Vic Hasselblad; Michel Komajda; Barrie Massie; John J V McMurray; Markku Nieminen; Jean L Rouleau; Karl Swedberg; Robert M Califf
Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
American heart journal 2009;157(2):271-7.
2009: Manesh R Patel; Matthias E Pfisterer; Amadeo Betriu; Petr Widmisky; David R Holmes; William W O'Neill; Amanda L Stebbins; Frans Van de Werf; Paul W Armstrong; Christopher B Granger
Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study).
The American journal of cardiology 2009;103(2):181-6.
2009: Justin A Ezekowitz; Padma Kaul; Jeffrey Bakal; Paul W Armstrong; Robert C Welsh; Finlay A McAlister
Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction.
Journal of the American College of Cardiology 2009;53(1):13-20.
2009: Paul W Armstrong
Contemporary therapy of acute ST-elevation myocardial infarction.
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 2009;36(4):273-81.
2008: Michelle M Graham; Cynthia M Westerhout; Padma Kaul; Colleen M Norris; Paul W Armstrong
Sex differences in patients seeking medical attention for prodromal symptoms before an acute coronary event.
American heart journal 2008;156(6):1210-1216.e1.
2008: Kenneth W Mahaffey; Craig J Reist; Yuling Fu; Sorin J Brener; Pierre Theroux; Manesh R Patel; Amanda Stebbins; Cynthia M Westerhout; Thomas G Todaro; Peter X Adams; Christopher B Granger; Paul W Armstrong
Integrating ancillary studies in a large clinical trial: the design and rationale of the APEX library.
Contemporary clinical trials 2008;29(6):887-95.
2008: Christopher E Buller; Yuling Fu; Kenneth W Mahaffey; Thomas G Todaro; Peter Adams; Cynthia M Westerhout; Harvey D White; Arnoud W J van 't Hof; Frans J Van de Werf; Galen S Wagner; Christopher B Granger; Paul W Armstrong
ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
Circulation 2008;118(13):1335-46.
2008: Kevin R Bainey; Yuling Fu; Galen S Wagner; Shaun G Goodman; Allan Ross; Christopher B Granger; Frans Van de Werf; Paul W Armstrong
Spontaneous reperfusion in ST-elevation myocardial infarction: comparison of angiographic and electrocardiographic assessments.
American heart journal 2008;156(2):248-55.
2008: Paul W Armstrong
Defining myocardial infarction: a work in progress: Ischaemic heart disease.
Heart (British Cardiac Society) 2008;94(8):1076-9.
2008: Paul W Armstrong; Jean-Lucien Rouleau
A Canadian context for the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF) trial.
The Canadian journal of cardiology 2008;24 Suppl B():30B-2B.
2008: R D Lopes; K S Pieper; J R Horton; Sana M Al-Khatib; L Kristin Newby; Rajendra H Mehta; Frans Van de Werf; Paul W Armstrong; K W Mahaffey; Robert A Harrington; Erik Ohman; Harvey D White; Lars Wallentin; Christopher B Granger
Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation.
Heart (British Cardiac Society) 2008;94(7):867-73.
2008: Sorin J Brener; David J Moliterno; Philip E Aylward; Arnoud W J van't Hof; Witold Ruźyllo; William W O'Neill; Christian W Hamm; Cynthia M Westerhout; Christopher B Granger; Paul W Armstrong
Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic study.
European heart journal 2008;29(9):1127-35.
2008: Paul W Armstrong
Requiem for the sounds of silence.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2008;178(8):1104.
2008: Martin T Schechter; Paul W Armstrong
The Canadian Academy of Health Sciences: coming of age at the right time.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2008;178(8):1029-31.
2008: Rajendra H Mehta; Sunil V Rao; Erik Ohman; Eric R Bates; Gretchen Marcucci; Min Zhang; Karen S Pieper; Paul W Armstrong; Harvey D White; Frans Van de Werf; Robert M Califf; Christopher B Granger
Variation in the use of stress testing and outcomes in patients with non-ST-elevation acute coronary syndromes: insights from GUSTO IIb.
European heart journal 2008;29(7):880-7.
2008: Michael A McDonald; Yuling Fu; Uwe Zeymer; Galen Wagner; Shaun G Goodman; Allan Ross; Christopher B Granger; Frans Van de Werf; Paul W Armstrong
Adverse outcomes in fibrinolytic-based facilitated percutaneous coronary intervention: insights from the ASSENT-4 PCI electrocardiographic substudy.
European heart journal 2008;29(7):871-9.
2008: Sumit R Majumdar; Matthew T Roe; Eric D Peterson; Anita Y Chen; W Brian Gibler; Paul W Armstrong
Better outcomes for patients treated at hospitals that participate in clinical trials.
Archives of internal medicine 2008;168(6):657-62.
2008: Justin A Ezekowitz; Jeffrey Bakal; Padma Kaul; Cynthia M Westerhout; Paul W Armstrong
Acute heart failure in the emergency department: short and long-term outcomes of elderly patients with heart failure.
European journal of heart failure 2008;10(3):308-14.
2008: Jeffrey S Berger; Amanda L Stebbins; Christopher B Granger; Erik Ohman; Paul W Armstrong; Frans Van de Werf; Harvey D White; R John Simes; Robert A Harrington; Robert M Califf; Eric D Peterson
Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapy.
Circulation 2008;117(2):192-9.
2008: Christopher E Buller; Robert C Welsh; Cynthia M Westerhout; John G Webb; Blair O'Neill; Richard Gallo; Paul W Armstrong
Guideline adjudicated fibrinolytic failure: incidence, findings, and management in a contemporary clinical trial.
American heart journal 2008;155(1):121-7.
2007: Michael C Tjandrawidjaja; Yuling Fu; Hussein R Al-Khalidi; Thomas G Todaro; Peter Adams; Frans Van de Werf; Christopher B Granger; Paul W Armstrong
Failure of investigator adherence to electrocardiographic entry criteria is frequent and influences clinical outcomes: lessons from APEX-AMI.
European heart journal 2007;28(23):2850-7.
2007: Padma Kaul; Wei-Ching Chang; Cynthia M Westerhout; Michelle M Graham; Paul W Armstrong
Differences in admission rates and outcomes between men and women presenting to emergency departments with coronary syndromes.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2007;177(10):1193-9.
2007: Daniel B Mark; Frans Van de Werf; R John Simes; Harvey D White; Lars Wallentin; Robert M Califf; Paul W Armstrong
Cardiovascular disease on a global scale: defining the path forward for research and practice.
European heart journal 2007;28(21):2678-84.
2007: Rajendra H Mehta; Adam B Greenbaum; Yuliya Lokhnygina; L Kristin Newby; Frans Van de Werf; Paul W Armstrong; Karen S Pieper; Robert M Califf; Christopher B Granger; Robert A Harrington
Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trials.
Journal of interventional cardiology 2007;20(5):299-306.
2007: Cynthia M Westerhout; Michael Lauer; Stefan James; Yuling Fu; Lars Wallentin; Paul W Armstrong
Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women.
European heart journal 2007;28(17):2064-9.
2007: Robert C Welsh; Phillip Gordon; Cynthia M Westerhout; Christopher E Buller; Blair O'Neill; Paul W Armstrong
A novel enoxaparin regime for ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a WEST sub-study.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2007;70(3):341-8.
2007: Cynthia M Westerhout; Judy Gnarpe; Wei-Ching Chang; Susan FitzPatrick; Elliot S Barnathan; eric boersma; Robert M Califf; Lars Wallentin; Maarten L Simoons; Paul W Armstrong
No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trial.
American heart journal 2007;154(2):306-12.
2007: Karen P Alexander; L Kristin Newby; Paul W Armstrong; Christopher P Cannon; W Brian Gibler; Michael W Rich; Frans Van de Werf; Harvey D White; W Douglas Weaver; Mary D Naylor; Joel M Gore; Harlan Krumholz; Erik Ohman
Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Circulation 2007;115(19):2570-89.
2007: Karen P Alexander; L Kristin Newby; Christopher P Cannon; Paul W Armstrong; W Brian Gibler; Michael W Rich; Frans Van de Werf; Harvey D White; W Douglas Weaver; Mary D Naylor; Joel M Gore; Harlan Krumholz; Erik Ohman
Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Circulation 2007;115(19):2549-69.
2007: Adrián V Hernández; Cynthia M Westerhout; Ewout W Steyerberg; John Ioannidis; Hector BUENO; Harvey White; Pierre Theroux; David J Moliterno; Paul W Armstrong; Robert M Califf; Lars Wallentin; Maarten L Simoons; eric boersma
Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups.
Heart (British Cardiac Society) 2007;93(4):450-5.
2007: Paul W Armstrong
Ruminating on OAT: is the case closed?
European heart journal 2007;28(5):531-2.
2007: Rajendra H Mehta; Robert M Califf; Jyotsna Garg; Harvey D White; Frans Van de Werf; Paul W Armstrong; Karen S Pieper; Eric J Topol; Christopher B Granger
The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarction.
European heart journal 2007;28(4):415-24.
2007: Paul W Armstrong; Christopher B Granger; Peter X Adams; Christian Hamm; David Holmes; William W O'Neill; Thomas G Todaro; Alec Vahanian; Frans Van de Werf
Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2007;297(1):43-51.
2007: Paul W Armstrong
A time for transformative leadership in academic health sciences.
Clinical and investigative medicine. Médecine clinique et experimentale 2007;30(3):E127-32.
2007: Justin A Ezekowitz; Pierre Théroux; Robert C Welsh; Iqbal Bata; John Webb; Paul W Armstrong
Insights into the change in brain natriuretic peptide after ST-elevation myocardial infarction (STEMI): why should it be better than baseline?
Canadian journal of physiology and pharmacology 2007;85(1):173-8.
2007: Wei-Ching Chang; Padma Kaul; Cynthia M Westerhout; Michelle M Graham; Paul W Armstrong
Effects of socioeconomic status on mortality after acute myocardial infarction.
The American journal of medicine 2007;120(1):33-9.
2006: Robert C Welsh; Andrew H Travers; Manohara P J Senaratne; Randall Williams; Paul W Armstrong
Feasibility and applicability of paramedic-based prehospital fibrinolysis in a large North American center.
American heart journal 2006;152(6):1007-14.
2006: Cynthia M Westerhout; Adrián V Hernández; Ewout W Steyerberg; Hector BUENO; Harvey White; Pierre Théroux; David J Moliterno; Paul W Armstrong; Robert M Califf; Lars Wallentin; Maarten L Simoons; eric boersma
Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes.
European heart journal 2006;27(24):2956-61.
2006: Paul W Armstrong
Advancing interdisciplinary health research: a synergism not to be denied.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2006;175(7):761.
2006: Cynthia M Westerhout; Yuling Fu; Michael Lauer; Stefan James; Paul W Armstrong; Eyad Al-Hattab; Robert M Califf; Maarten L Simoons; Lars Wallentin; eric boersma
Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers.
Journal of the American College of Cardiology 2006;48(5):939-47.
2006: Kenneth W Mahaffey; Frans Van de Werf; Stanton K Shernan; Christopher B Granger; Edward D Verrier; Thomas G Filloon; Thomas G Todaro; Peter X Adams; Jerrold H Levy; Vic Hasselblad; Paul W Armstrong
Effect of pexelizumab on mortality in patients with acute myocardial infarction or undergoing coronary artery bypass surgery: a systematic overview.
American heart journal 2006;152(2):291-6.
2006: Karen P Alexander; L Kristin Newby; Manjushri Bhapkar; Harvey D White; Judith S Hochman; Matthias E Pfisterer; David J Moliterno; eric peterson; Frans Van de Werf; Paul W Armstrong; Robert M Califf
International variation in invasive care of the elderly with acute coronary syndromes.
European heart journal 2006;27(13):1558-64.
2006: Paul W Armstrong
A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study.
European heart journal 2006;27(13):1530-8.
2006: Finlay A McAlister; William A Ghali; Yanyan Gong; Jiming Fang; Paul W Armstrong; Jack V Tu
Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure.
Circulation 2006;113(22):2572-8.
2006: Abhinav Goyal; Kenneth W Mahaffey; Jyotsna Garg; Jose C Nicolau; Judith S Hochman; W Douglas Weaver; Pierre Theroux; Gustavo B F Oliveira; Thomas G Todaro; Christopher F Mojcik; Paul W Armstrong; Christopher B Granger
Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study.
European heart journal 2006;27(11):1289-97.
2006: Paul W Armstrong
Balancing the cyclooxygenase portfolio.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2006;174(11):1581-2.
2006: Paul W Armstrong; Wei-Ching Chang; Lars Wallentin; Patrick Goldstein; Christopher B Granger; Kris Bogaerts; Thierry Danays; Frans Van de Werf
Efficacy and safety of unfractionated heparin versus enoxaparin: a pooled analysis of ASSENT-3 and -3 PLUS data.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2006;174(10):1421-6.
2006: Christopher E Buller; Gordon E Pate; Paul W Armstrong; Blair O'Neill; John G Webb; Richard Gallo; Robert C Welsh
Catheter thrombosis during primary percutaneous coronary intervention for acute ST elevation myocardial infarction despite subcutaneous low-molecular-weight heparin, acetylsalicylic acid, clopidogrel and abciximab pretreatment.
The Canadian journal of cardiology 2006;22(6):511-5.
2006: Padma Kaul; Wei-Ching Chang; A Michael Lincoff; Philip E Aylward; Amadeo Betriu; Christoph Bode; Robert M Califf; Erik Ohman; Victor Guetta; Philippe Gabriel STEG; Frans Van de Werf; Paul W Armstrong
Optimizing use of revascularization and clinical outcomes in ST-elevation myocardial infarction: insights from the GUSTO-V trial.
European heart journal 2006;27(10):1198-206.
2006: Justin A Ezekowitz; Pierre Théroux; Weiching Chang; Kenneth W Mahaffey; Christopher B Granger; W Douglas Weaver; Judith S Hochman; Paul W Armstrong
N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarction.
The Canadian journal of cardiology 2006;22(5):393-7.
2006: Paul W Armstrong; Kenneth W Mahaffey; Wei-Ching Chang; W Douglas Weaver; Judith S Hochman; Pierre Theroux; Scott A Rollins; Thomas G Todaro; Christopher B Granger
Concerning the mechanism of pexelizumab's benefit in acute myocardial infarction.
American heart journal 2006;151(4):787-90.
2006: Mustafa Toma; Finlay A McAlister; Liza Bialy; Denise Adams; Ben Vandermeer; Paul W Armstrong
Transition from meeting abstract to full-length journal article for randomized controlled trials.
JAMA : the journal of the American Medical Association 2006;295(11):1281-7.
2006: Mustafa Toma; Finlay A McAlister; Justin A Ezekowitz; Shane Kimber; Sajad Gulamhusein; Alfredo Pantano; Soori Sivakumaran; Bibiana Cujec; Ian Paterson; Paul W Armstrong
Proportion of patients followed in a specialized heart failure clinic needing an implantable cardioverter defibrillator as determined by applying different trial eligibility criteria.
The American journal of cardiology 2006;97(6):882-5.
2006: Ahmad Hersi; Paul W Armstrong; Jonathan B Choy; Sajad Gulamhusein; Katherine M Kavanagh
Pulmonary edema post-cardioversion: a potential calcium signalling problem.
The Canadian journal of cardiology 2006;22(3):259-62.
2006: Daniel H Kim; Jeffrey R Burton; Yuling Fu; Lee Lindholm; Frans Van de Werf; Paul W Armstrong
What is the frequency and functional and clinical significance of complex lesions in non-infarct-related arteries after fibrinolysis for acute ST-elevation myocardial infarction?
American heart journal 2006;151(3):668-73.
2006: Sunil V Rao; Kristi O'Grady; Karen S Pieper; Christopher B Granger; L Kristin Newby; Kenneth W Mahaffey; David J Moliterno; A Michael Lincoff; Paul W Armstrong; Frans Van de Werf; Robert M Califf; Robert A Harrington
A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes.
Journal of the American College of Cardiology 2006;47(4):809-16.
2006: Wei-Ching Chang; Padma Kaul; Yuling Fu; Cynthia M Westerhout; Christopher B Granger; Kenneth W Mahaffey; Lars Wallentin; Frans Van de Werf; Paul W Armstrong
Forecasting mortality: dynamic assessment of risk in ST-segment elevation acute myocardial infarction.
European heart journal 2006;27(4):419-26.
2006: Finlay A McAlister; Jack V Tu; Alice Newman; Douglas S Lee; Shane Kimber; Bibiana Cujec; Paul W Armstrong
How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts.
European heart journal 2006;27(3):323-9.
2006: John M Galla; Kenneth W Mahaffey; Shelly K Sapp; John H Alexander; Matthew T Roe; Erik Ohman; Christopher B Granger; Paul W Armstrong; Robert A Harrington; Harvey D White; Maarten L Simoons; L Kristin Newby; Robert M Califf; Eric J Topol
Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials.
American heart journal 2006;151(1):16-24.
2006: Hussam Al-Faleh; Yuling Fu; Galen Wagner; Shaun Goodman; Elena Sgarbossa; Christopher Granger; Frans Van de Werf; Lars Wallentin; Paul W Armstrong
Unraveling the spectrum of left bundle branch block in acute myocardial infarction: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT 2 and 3) trials.
American heart journal 2006;151(1):10-5.
2005: Camille G Frazier; Svati H Shah; Paul W Armstrong; Manjushri Bhapkar; Darren K McGuire; Zygmunt Sadowski; Arni Kristinsson; Philip E Aylward; Werner W Klein; W Douglas Weaver; L Kristin Newby
Prevalence and management of hypertension in acute coronary syndrome patients varies by sex: observations from the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes (SYMPHONY) randomized clinical trials.
American heart journal 2005;150(6):1260-7.
2005: Robert C Welsh; Paul W Armstrong
It's a matter of time: contemporary pre-hospital management of acute ST elevation myocardial infarction.
Heart (British Cardiac Society) 2005;91(12):1524-6.
2005: David E Kandzari; Jean-Pierre Dery; Paul W Armstrong; Deborah A Douglas; Marjorie E Zettler; G Karl-Gunnar Hidinger; Albert D Friesen; Robert A Harrington
MC-1 (pyridoxal 5'-phosphate): novel therapeutic applications to reduce ischaemic injury.
Expert opinion on investigational drugs 2005;14(11):1435-42.
2005: Robert C Welsh; W Chang; Patrick Goldstein; J Adgey; Christopher B Granger; Freek W A Verheugt; Lars Wallentin; Frans Van de Werf; Paul W Armstrong
Time to treatment and the impact of a physician on prehospital management of acute ST elevation myocardial infarction: insights from the ASSENT-3 PLUS trial.
Heart (British Cardiac Society) 2005;91(11):1400-6.
2005: Pierre Théroux; Paul W Armstrong; Kenneth W Mahaffey; Judith S Hochman; Kevin J Malloy; Scott A Rollins; Jose C Nicolau; Joel Lavoie; The Minh Luong; Jeb Burchenal; Christopher B Granger
Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial.
European heart journal 2005;26(19):1964-70.
2005: Sorin J Brener; A Michael Lincoff; Eric R Bates; Gang Jia; Paul W Armstrong; Victor Guetta; Judith S Hochman; Stefano Savonitto; Robert G Wilcox; Harvey D White; Eric J Topol
The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: insights from the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trial.
American heart journal 2005;150(1):89-93.
2005: Michael C Tjandrawidjaja; Yuling Fu; Daniel H Kim; Jeffrey R Burton; Lee Lindholm; Paul W Armstrong
Compromised atrial coronary anatomy is associated with atrial arrhythmias and atrioventricular block complicating acute myocardial infarction.
Journal of electrocardiology 2005;38(3):271-8.
2005: P Kaul; L Kristin Newby; Y Fu; Daniel B Mark; Shaun G Goodman; Galen S Wagner; Robert A Harrington; Christopher B Granger; Frans Van de Werf; Erik Ohman; Paul W Armstrong
Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination of international practice patterns.
Heart (British Cardiac Society) 2005;91(7):876-81.
2005: Wei-Ching Chang; William K Midodzi; Cynthia M Westerhout; eric boersma; Judith Cooper; Elliot S Barnathan; Maarten L Simoons; Lars Wallentin; Erik Ohman; Paul W Armstrong
Are international differences in the outcomes of acute coronary syndromes apparent or real? A multilevel analysis.
Journal of epidemiology and community health 2005;59(5):427-33.
2005: Rajendra H Mehta; John H Alexander; Frans Van de Werf; Paul W Armstrong; Karen S Pieper; Jyotsna Garg; Robert M Califf; Christopher B Granger
Relationship of incorrect dosing of fibrinolytic therapy and clinical outcomes.
JAMA : the journal of the American Medical Association 2005;293(14):1746-50.
2005: Paul W Armstrong; Peter X Adams; Hussein R Al-Khalidi; Christian Hamm; David Holmes; William W O'Neill; Thomas G Todaro; Alec Vahanian; Frans Van de Werf; Christopher B Granger
Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
American heart journal 2005;149(3):402-7.
2005: John H Alexander; Hongqiu Yang; Richard C Becker; K Kodama; S Goodman; Christopher K Dyke; Neal S Kleiman; Judith S Hochman; P B Berger; E A Cohen; A Michael Lincoff; J R Burton; Edwin G Bovill; C Kawai; Paul W Armstrong; Robert A Harrington
First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial.
Journal of thrombosis and haemostasis : JTH 2005;3(3):439-47.
2005: Manesh R Patel; Kenneth W Mahaffey; Paul W Armstrong; W Douglas Weaver; Gudaye Tasissa; Judith S Hochman; Thomas G Todaro; Kevin J Malloy; Scott A Rollins; Pierre Theroux; Witold Ruzyllo; Jose C Nicolau; Christopher B Granger
Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial).
The American journal of cardiology 2005;95(5):614-8.
2005: Justin A Ezekowitz; Finlay A McAlister; Paul W Armstrong
The interaction among sex, hemoglobin and outcomes in a specialty heart failure clinic.
The Canadian journal of cardiology 2005;21(2):165-71.
2005: Justin A Ezekowitz; Carl van Walraven; Finlay A McAlister; Paul W Armstrong; Padma Kaul
Impact of specialist follow-up in outpatients with congestive heart failure.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2005;172(2):189-94.
2005: Marino Labinaz; Jasmine Mathias; Karen S Pieper; Christopher B Granger; A Michael Lincoff; David J Moliterno; Frans Van de Werf; R John Simes; Harvey D White; Maarten L Simoons; Robert M Califf; Eric J Topol; Paul W Armstrong; Robert A Harrington
Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials.
European heart journal 2005;26(2):128-36.
2004: Paul W Armstrong; L Kristin Newby; Christopher B Granger; Kerry L Lee; R John Simes; Frans Van de Werf; Harvey D White; Robert M Califf
Lessons learned from a clinical trial.
Circulation 2004;110(23):3610-4.
2004: Robert C Welsh; Paul W Armstrong
A marriage of enhancement: fibrinolysis and conjunctive therapy.
Thrombosis and haemostasis 2004;92(6):1194-200.
2004: Eric J Velazquez; Gary S Francis; Paul W Armstrong; Philip E Aylward; Rafael Diaz; Christopher M O'Connor; Harvey D White; Marc Henis; Lois M Rittenhouse; Rakhi Kilaru; Wiek H van Gilst; Georg Ertl; Aldo P Maggioni; Jiri Spac; W Douglas Weaver; Jean-Lucien Rouleau; john mcmurray; Marc A Pfeffer; Robert M Califf
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry.
European heart journal 2004;25(21):1911-9.
2004: Sunil V Rao; James G Jollis; Robert A Harrington; Christopher B Granger; L Kristin Newby; Paul W Armstrong; David J Moliterno; Lauren Lindblad; Karen S Pieper; Eric J Topol; Jonathan S Stamler; Robert M Califf
Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes.
JAMA : the journal of the American Medical Association 2004;292(13):1555-62.
2004: Padma Kaul; Paul W Armstrong; Wei-Ching Chang; C David Naylor; Christopher B Granger; Kerry L Lee; Eric D Peterson; Robert M Califf; Eric J Topol; Daniel B Mark
Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I.
Circulation 2004;110(13):1754-60.
2004: Paul W Armstrong; Peter Bogaty; Christopher E Buller; Paul Dorian; Blair O'Neill
The 2004 ACC/AHA Guidelines: a perspective and adaptation for Canada by the Canadian Cardiovascular Society Working Group.
The Canadian journal of cardiology 2004;20(11):1075-9.
2004: Jeptha P Curtis; John H Alexander; Yao Huang; Lars Wallentin; Freek W A Verheugt; Paul W Armstrong; Harlan Krumholz; Frans Van de Werf; Thierry Danays; Morris Cheeks; Christopher B Granger
Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3).
The American journal of cardiology 2004;94(3):279-83.
2004: Taha Taher; Yuling Fu; Galen S Wagner; Shaun G Goodman; Claudio Fresco; Christopher B Granger; Lars Wallentin; Frans Van de Werf; Freek W A Verheugt; Paul W Armstrong
Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy.
Journal of the American College of Cardiology 2004;44(1):38-43.
2004: Wei-Ching Chang; eric boersma; Christopher B Granger; Robert A Harrington; Robert M Califf; Maarten L Simoons; Neal S Kleiman; Paul W Armstrong
Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUIT.
American heart journal 2004;148(1):62-71.
2004: Marino Labinaz; Padma Kaul; Robert A Harrington; Wei-Ching Chang; Neal S Kleiman; Maarten L Simoons; eric boersma; K Martijn Akkerhuis; Robert M Califf; Paul W Armstrong
Six-month outcomes of percutaneous coronary balloon angioplasty in acute coronary syndromes: Results from the PURSUIT trial.
The Canadian journal of cardiology 2004;20(8):773-8.
2004: Padma Kaul; Paul W Armstrong; Yuling Fu; J David Knight; Nancy E Clapp-Channing; Wanda Sutherland; Christopher B Granger; Daniel B Mark
Impact of different patterns of invasive care on quality of life outcomes in patients with non-ST elevation acute coronary syndrome: results from the GUSTO-IIb Canada-United States substudy.
The Canadian journal of cardiology 2004;20(8):760-6.
2004: Robert C Welsh; Patrick Goldstein; Jennifer Adgey; Freek W A Verheugt; Shirley A Bestilny; Lars Wallentin; Frans Van de Werf; Paul W Armstrong
Variations in pre-hospital fibrinolysis process of care: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic 3 Plus international acute myocardial infarction pre-hospital care survey.
European journal of emergency medicine : official journal of the European Society for Emergency Medicine 2004;11(3):134-40.
2004: Sumit R Majumdar; Finlay A McAlister; Marilyn Cree; Wei-Ching Chang; Milton Packer; Paul W Armstrong
Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study.
Clinical therapeutics 2004;26(5):694-703.
2004: Timo Lenderink; eric boersma; Witold Ruzyllo; Petr Widimsky; Erik Ohman; Paul W Armstrong; Lars Wallentin; Maarten L Simoons
Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS.
American heart journal 2004;147(5):865-73.
2004: Puneeta Tandon; Finlay A McAlister; Ross T Tsuyuki; Marilou Hervas-Malo; Ruth Dupuit; Justin A Ezekowitz; Bibiana Cujec; Paul W Armstrong
The use of beta-blockers in a tertiary care heart failure clinic: dosing, tolerance, and outcomes.
Archives of internal medicine 2004;164(7):769-74.
2004: Arthur C P Maas; Christina M Wyatt; Cynthia L Green; Galen S Wagner; Kathleen M Trollinger; James E Pope; Anatoly Langer; Paul W Armstrong; Robert M Califf; Maarten L Simoons; Mitchell W Krucoff
Combining baseline clinical descriptors and real-time response to therapy: the incremental prognostic value of continuous ST-segment monitoring in acute myocardial infarction.
American heart journal 2004;147(4):698-704.
2004: Manesh R Patel; Paul W Armstrong
To transfer or not to transfer: acute myocardial infarction reperfusion.
American heart journal 2004;147(4):573-4.
2004: Cynthia M Westerhout; L Duncan Saunders; Padma Kaul; Paul W Armstrong; Merril L Knudtson; William A Ghali
Interinstitutional variation in the use of abciximab for percutaneous coronary intervention.
The Canadian journal of cardiology 2004;20(4):405-10.
2004: Finlay A McAlister; Justin A Ezekowitz; Marcello Tonelli; Paul W Armstrong
Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study.
Circulation 2004;109(8):1004-9.
2004: Hitinder S Gurm; A Michael Lincoff; David S Lee; W H Wilson Tang; Gang Jia; Joan E Booth; Robert M Califf; Erik Ohman; Frans Van de Werf; Paul W Armstrong; Victor Guetta; Robert Wilcox; Eric J Topol
Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial.
Journal of the American College of Cardiology 2004;43(4):542-8.
2004: Padma Kaul; L Kristin Newby; Yuling Fu; Daniel B Mark; Robert M Califf; Eric J Topol; Phil Aylward; Christopher B Granger; Frans Van de Werf; Paul W Armstrong
International differences in evolution of early discharge after acute myocardial infarction.
Lancet 2004;363(9408):511-7.
2004: Karen S Pieper; Anastasios A Tsiatis; Marie Davidian; Vic Hasselblad; Neal S Kleiman; Eric Boersma; Wei-Ching Chang; Jeffrey Griffin; Paul W Armstrong; Robert M Califf; Robert A Harrington
Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methods.
Circulation 2004;109(5):641-6.
2004: Paul W Armstrong; Christina Ezekowitz; Evangelos D Michelakis; Todd Anderson; Stephen Archer; William Ghali; Robert Hayward; Louise Jensen; Gary D Lopaschuk; Robert Sheldon
Innovative strategic Canadian research training from TomorrOw's Research Cardiovascular Health Care Professionals (TORCH).
Clinical and investigative medicine. Médecine clinique et experimentale 2004;27(1):33-41.
2004: John H Alexander; Christopher K Dyke; Hongqiu Yang; Richard C Becker; Vic Hasselblad; Linda A Zillman; Neal S Kleiman; Judith S Hochman; P B Berger; E A Cohen; A Michael Lincoff; Henock Saint-Jacques; Stanley Chetcuti; J R Burton; J M Buergler; F P Spence; Yoshimasa Shimoto; Thomas L Robertson; Satoshi Kunitada; Edwin G Bovill; Paul W Armstrong; Robert A Harrington
Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI Pilot.
Journal of thrombosis and haemostasis : JTH 2004;2(2):234-41.
2004: Matthew T Roe; Kenneth W Mahaffey; Rakhi Kilaru; John H Alexander; K Martijn Akkerhuis; Maarten L Simoons; Robert A Harrington; Barbara E Tardiff; Christopher B Granger; Erik Ohman; David J Moliterno; A Michael Lincoff; Paul W Armstrong; Frans Van de Werf; Robert M Califf; Eric J Topol
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.
European heart journal 2004;25(4):313-21.
2004: Taha H Taher; Linda Stang; Philip A Gordon; Paul W Armstrong
Clopidogrel does not induce fibrinolysis in healthy subjects.
Thrombosis research 2004;114(2):97-100.
2003: L Kristin Newby; Manjushri Bhapkar; Harvey D White; David J Moliterno; Nancy M Allen LaPointe; David E Kandzari; Freek W A Verheugt; Judith M Kramer; Paul W Armstrong; Robert M Califf
Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation.
Journal of thrombosis and thrombolysis 2003;16(3):119-28.
2003: Judith M Kramer; L Kristin Newby; Wei Ching Chang; R John Simes; Frans Van de Werf; Christopher B Granger; Kerry L Lee; Harvey D White; Leopoldo Soares Piegas; Eric J Topol; Robert M Califf; Paul W Armstrong
International variation in the use of evidence-based medicines for acute coronary syndromes.
European heart journal 2003;24(23):2133-41.
2003: Wei-Ching Chang; Padma Kaul; Cynthia M Westerhout; Michelle M Graham; Yuling Fu; Tapan Chowdhury; Paul W Armstrong
Impact of sex on long-term mortality from acute myocardial infarction vs unstable angina.
Archives of internal medicine 2003;163(20):2476-84.
2003: eric peterson; Padma Kaul; Ronald G Kaczmarek; Bradley G Hammill; Paul W Armstrong; Charles R Bridges; T. Bruce Ferguson
From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes.
Journal of the American College of Cardiology 2003;42(9):1611-6.
2003: Paul W Armstrong; Robert C Welsh
Tailoring therapy to best suit ST-segment elevation myocardial infarction: searching for the right fit.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2003;169(9):925-7.
2003: Evan Lockwood; Yuling Fu; Brian Wong; Frans Van de Werf; Christopher B Granger; Paul W Armstrong; Shaun G Goodman
Does 24-hour ST-segment resolution postfibrinolysis add prognostic value to a Q wave? An ASSENT 2 electrocardiographic substudy.
American heart journal 2003;146(4):640-5.
2003: Kenneth W Mahaffey; Christopher B Granger; Jose C Nicolau; Witold Ruzyllo; W Douglas Weaver; Pierre Theroux; Judith S Hochman; Thomas G Filloon; Christopher F Mojcik; Thomas G Todaro; Paul W Armstrong
Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial.
Circulation 2003;108(10):1176-83.
2003: Christopher B Granger; Kenneth W Mahaffey; W Douglas Weaver; Pierre Theroux; Judith S Hochman; Thomas G Filloon; Scott A Rollins; Thomas G Todaro; Jose C Nicolau; Witold Ruzyllo; Paul W Armstrong
Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial.
Circulation 2003;108(10):1184-90.
2003: Paul W Armstrong; J Burton; S Pakola; P G Molhoek; Amadeo Betriu; M Tendera; C Bode; A A Jennifer Adgey; F Bar; Alec Vahanian; Frans Van de Werf
Collaborative Angiographic Patency Trial Of Recombinant Staphylokinase (CAPTORS II).
American heart journal 2003;146(3):484-8.
2003: Paul W Armstrong; Galen Wagner; Shaun G Goodman; Frans Van de Werf; Christopher Granger; Lars Wallentin; Yuling Fu
ST segment resolution in ASSENT 3: insights into the role of three different treatment strategies for acute myocardial infarction.
European heart journal 2003;24(16):1515-22.
2003: Lars Wallentin; Patrick Goldstein; Paul W Armstrong; Christopher B Granger; A A Jennifer Adgey; H R Arntz; K Bogaerts; Thierry Danays; Bertil Lindahl; Markku Makijarvi; Freek W A Verheugt; Frans Van de Werf
Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction.
Circulation 2003;108(2):135-42.
2003: Jonathan B Choy; Paul W Armstrong; Raymond A Ulan; Patricia M Campbell; Sita Gourishankar; Connie Prosser; Wayne Tymchak
Do cardiac troponins provide prognostic insight in hemodialysis patients?
The Canadian journal of cardiology 2003;19(8):907-11.
2003: Michael C Tjandrawidjaja; Yuling Fu; Shaun G Goodman; Frans Van de Werf; Christopher B Granger; Paul W Armstrong
The impact of gender on the treatment and outcomes of patients with early reinfarction after fibrinolysis: insights from ASSENT-2.
European heart journal 2003;24(11):1024-34.
2003: Paul W Armstrong; Désiré Collen; Elliott M Antman
Fibrinolysis for acute myocardial infarction: the future is here and now.
Circulation 2003;107(20):2533-7.
2003: Paul W Armstrong
Two hard lessons.
Lancet 2003;361(9367):1417.
2003: Sunil V Rao; Erik Ohman; Christopher B Granger; Paul W Armstrong; W Brian Gibler; Robert H Christenson; Vic Hasselblad; Amanda Stebbins; Steven McNulty; L Kristin Newby
Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes.
The American journal of cardiology 2003;91(8):936-40.
2003: Justin A Ezekowitz; Paul W Armstrong; Finlay A McAlister
Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials.
Annals of internal medicine 2003;138(6):445-52.
2003: Fadi H Khadour; Yuling Fu; Wei-Ching Chang; Xin Ma; Daniel Mark; Christopher B Granger; Eric J Topol; Robert M Califf; Paul W Armstrong
Impact of on-site cardiac interventional facilities on management and outcome of patients with acute coronary syndromes.
The Canadian journal of cardiology 2003;19(3):257-63.
2003: Sana M Al-Khatib; Amanda L Stebbins; Robert M Califf; Kerry L Lee; Christopher B Granger; Harvey D White; Paul W Armstrong; Eric J Topol; Erik Ohman
Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial.
American heart journal 2003;145(3):515-21.
2003: A Hersi; Yuling Fu; B Wong; Kenneth W Mahaffey; Robert A Harrington; Robert M Califf; Frans Van de Werf; Paul W Armstrong
Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission?
European heart journal 2003;24(6):522-31.
2003: Paul W Armstrong
Do guidelines influence practice?
Heart (British Cardiac Society) 2003;89(3):349-52.
2003: Padma Kaul; L Kristin Newby; Yuling Fu; Vic Hasselblad; Kenneth W Mahaffey; Robert H Christenson; Robert A Harrington; Erik Ohman; Eric J Topol; Robert M Califf; Frans Van de Werf; Paul W Armstrong
Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients.
Journal of the American College of Cardiology 2003;41(3):371-80.
2003: Wayne B Batchelor; Daniel B Mark; J David Knight; Christopher B Granger; Paul W Armstrong; Robert M Califf; eric peterson
Development and validation of a simple model to predict severe coronary artery disease after myocardial infarction: potential impact on cardiac catheterization use in the United States and Canada.
American heart journal 2003;145(2):349-55.
2003: Justin A Ezekowitz; Finlay A McAlister; Paul W Armstrong
Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure.
Circulation 2003;107(2):223-5.
2003: Robert C Welsh; Joseph Ornato; Paul W Armstrong
Prehospital management of acute ST-elevation myocardial infarction: a time for reappraisal in North America.
American heart journal 2003;145(1):1-8.
2002: J Conor O'Shea; Robert G Wilcox; Allan Michael Skene; Amanda L Stebbins; Christopher B Granger; Paul W Armstrong; Christoph Bode; Diego Ardissino; Hakan Emanuelsson; Philip E Aylward; Harvey D White; Zygmunt Sadowski; Eric J Topol; Robert M Califf; Erik Ohman
Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone.
The American journal of cardiology 2002;90(12):1374-7.
2002: Brian Y L Wong; Judy Gnarpe; Koon K Teo; Erik Ohman; Connie Prosser; W Brian Gibler; Anatoly Langer; Wei-Ching Chang; Paul W Armstrong
Does chronic Chlamydia pneumoniae infection increase the risk of myocardial injury? Insights from patients with non-ST-elevation acute coronary syndromes.
American heart journal 2002;144(6):987-94.
2002: Justin A Ezekowitz; Paul W Armstrong
The waiting game: facing the consequences.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2002;167(11):1247-8.
2002: A Michael Lincoff; Robert M Califf; Frans Van de Werf; James T Willerson; Harvey D White; Paul W Armstrong; Victor Guetta; W Brian Gibler; Judith S Hochman; Christoph Bode; Alec Vahanian; Philippe Gabriel STEG; Diego Ardissino; Stefano Savonitto; Frits Bar; Zygmunt Sadowski; Amadeo Betriu; Joan E Booth; Kathy Wolski; Michael Waller; Eric J Topol
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial.
JAMA : the journal of the American Medical Association 2002;288(17):2130-5.
2002: Sumit R Majumdar; Wei-Ching Chang; Paul W Armstrong
Do the investigative sites that take part in a positive clinical trial translate that evidence into practice?
The American journal of medicine 2002;113(2):140-5.
2002: Sana M Al-Khatib; Christopher B Granger; Yao Huang; Kerry L Lee; Robert M Califf; Maarten L Simoons; Paul W Armstrong; Frans Van de Werf; Harvey D White; R John Simes; David J Moliterno; Eric J Topol; Robert A Harrington
Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes.
Circulation 2002;106(3):309-12.
2002: R David Anderson; Harvey D White; Erik Ohman; Galen S Wagner; Mitchell W Krucoff; Paul W Armstrong; W Douglas Weaver; W Brian Gibler; Amanda L Stebbins; Robert M Califf; Eric J Topol
Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global Use of Strategies To Open occluded coronary arteries.
American heart journal 2002;144(1):81-8.
2002: Wei-Ching Chang; Robert A Harrington; Maarten L Simoons; Robert M Califf; A Michael Lincoff; Paul W Armstrong
Does eptifibatide confer a greater benefit to patients with unstable angina than with non-ST segment elevation myocardial infarction? Insights from the PURSUIT Trial.
European heart journal 2002;23(14):1102-11.
2002: L Kristin Newby; Robert M Califf; Harvey D White; Robert A Harrington; Frans Van de Werf; Christopher B Granger; R John Simes; Vic Hasselblad; Paul W Armstrong
The failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac events.
The American journal of medicine 2002;112(8):647-58.
2002: Christopher K Dyke; Richard C Becker; Neal S Kleiman; Judith S Hochman; Edwin G Bovill; A Michael Lincoff; Gary Gerstenblith; Vladimir Dzavik; Laura H Gardner; Vic Hasselblad; Linda A Zillman; Yoshimasa Shimoto; Thomas L Robertson; Satoshi Kunitada; Paul W Armstrong; Robert A Harrington
First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation.
Circulation 2002;105(20):2385-91.
2002: Paul W Armstrong
Coronary reperfusion: numerators searching for denominators.
Lancet 2002;359(9304):371-2.
2002: Kenneth W Mahaffey; Matthew T Roe; Christopher K Dyke; L Kristin Newby; Neal S Kleiman; Patty Connolly; Lisa G Berdan; rodney sparapani; Kerry L Lee; Paul W Armstrong; Eric J Topol; Robert M Califf; Robert A Harrington
Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network Trial.
American heart journal 2002;143(2):242-8.
2002: Marino Labinaz; Rakhi Kilaru; Karen S Pieper; Steven P Marso; Michael M Kitt; Maarten L Simoons; Robert M Califf; Eric J Topol; Paul W Armstrong; Robert A Harrington
Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.
Circulation 2002;105(3):322-7.
2002: eric boersma; Robert A Harrington; David J Moliterno; Harvey White; Pierre Théroux; Frans Van de Werf; Anneke de Torbal; Paul W Armstrong; Lars Wallentin; Robert G Wilcox; R John Simes; Robert M Califf; Eric J Topol; Maarten L Simoons
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials.
Lancet 2002;359(9302):189-98.
2001: Matthew T Roe; Christopher B Granger; JA Puma; Anne S Hellkamp; Judith S Hochman; Erik Ohman; Harvey D White; Frans Van de Werf; Paul W Armstrong; S G Ellis; Robert M Califf; Eric J Topol
Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention.
The American journal of cardiology 2001;88(12):1403-6, A6.
2001: Yuling Fu; S Goodman; Wei-Ching Chang; Frans Van de Werf; Christopher B Granger; Paul W Armstrong
Time to treatment influences the impact of ST-segment resolution on one-year prognosis: insights from the assessment of the safety and efficacy of a new thrombolytic (ASSENT-2) trial.
Circulation 2001;104(22):2653-9.
2001: Finlay A McAlister; FM Lawson; KK Teo; Paul W Armstrong
Randomised trials of secondary prevention programmes in coronary heart disease: systematic review.
BMJ (Clinical research ed.) 2001;323(7319):957-62.
2001: Paul W Armstrong
New advances in the management of acute coronary syndromes: 2. Fibrinolytic therapy for acute ST-segment elevation myocardial infarction.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2001;165(6):791-7.
2001: Michael P Hudson; Christopher B Granger; Eric J Topol; Karen S Pieper; Paul W Armstrong; G I Barbash; AD Guerci; A Vahanian; Robert M Califf; Erik Ohman
Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials.
Circulation 2001;104(11):1229-35.
2001: P Kaul; Yuling Fu; W C Chang; Robert A Harrington; Galen S Wagner; Shaun G Goodman; Christopher B Granger; D J Moliterno; Frans Van de Werf; Robert M Califf; Eric J Topol; Paul W Armstrong
Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization Network.
Journal of the American College of Cardiology 2001;38(1):64-71.
2001: J Conor O'Shea; Y Fu; W C Chang; Paul W Armstrong
A tale of two countries: Insights from the differences in Canadian/American patterns of care for patients with acute coronary syndromes.
American heart journal 2001;142(1):14-20.
2001: Paul W Armstrong; Désiré Collen
Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 2.
Circulation 2001;103(24):2987-92.
2001: L Kristin Newby; Erik Ohman; Robert H Christenson; D J Moliterno; Robert A Harrington; Harvey D White; Paul W Armstrong; Frans Van de Werf; M Pfisterer; Vic Hasselblad; Robert M Califf; Eric J Topol
Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy.
Circulation 2001;103(24):2891-6.
2001: Paul W Armstrong; Désiré Collen
Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 1.
Circulation 2001;103(23):2862-6.
2001: Paul W Armstrong
New advances in the management of acute coronary syndromes.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2001;164(9):1303-4.
2001: Herbert D Aronow; Eric J Topol; M T Roe; Penny L Houghtaling; Kathy Wolski; A Michael Lincoff; Robert A Harrington; Robert M Califf; Erik Ohman; Neal S Kleiman; Mátyás Keltai; Robert G Wilcox; Alec Vahanian; Paul W Armstrong; Michael Lauer
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study.
Lancet 2001;357(9262):1063-8.
2001: Finlay A McAlister; FM Lawson; KK Teo; Paul W Armstrong
A systematic review of randomized trials of disease management programs in heart failure.
The American journal of medicine 2001;110(5):378-84.
2001: Maria Cecilia Bahit; Eric J Topol; Robert M Califf; Paul W Armstrong; Douglas A Criger; Vic Hasselblad; A Betriu; J Hirsh; D Ardissino; Christopher B Granger
Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes.
Journal of the American College of Cardiology 2001;37(4):1001-7.
2001: Paul W Armstrong; Christopher Granger; Frans Van de Werf
Bolus fibrinolysis: risk, benefit, and opportunities.
Circulation 2001;103(8):1171-3.
2000: Eric J Topol; Erik Ohman; Paul W Armstrong; Robert Wilcox; Allan Michael Skene; Philip E Aylward; R John Simes; A Dalby; Amadeo Betriu; C Bode; Harvey D White; Judith S Hochman; H Emanuelson; A Vahanian; Shelly K Sapp; Amanda L Stebbins; David J Moliterno; Robert M Califf
Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial.
Circulation 2000;102(15):1761-5.
2000: Wei-Ching Chang; Yuling Fu; Erik Ohman; M Gupta; A Morris; S N Roth; Christopher B Granger; Robert M Califf; Eric J Topol; Daniel B Mark; Paul W Armstrong
Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigators.
The Canadian journal of cardiology 2000;16(10):1231-9.
2000: Yuling Fu; Wei-Ching Chang; Daniel Mark; Robert M Califf; B Mackenzie; Christopher B Granger; Eric J Topol; M Hlatky; Paul W Armstrong
Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial: one-year follow-up of patients without ST-segment elevation. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) II Investigators.
Circulation 2000;102(12):1375-81.
2000: Paul W Armstrong
Left ventricular dysfunction: causes, natural history, and hopes for reversal.
Heart (British Cardiac Society) 2000;84 Suppl 1():i15-7:discussion i50.
2000: Robert A Harrington; Paul W Armstrong; Carmelo Graffagnino; Frans Van de Werf; Dean J Kereiakes; Kristina N Sigmon; T Card; Diane M Joseph; R Samuels; Jeffrey Granett; R Chan; Robert M Califf; Eric J Topol
Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic disease.
Circulation 2000;102(7):728-35.
2000: Alejandro Barbagelata; Robert M Califf; Elena B Sgarbossa; Shaun G Goodman; D Knight; Daniel B Mark; Christopher B Granger; D A Agranatti; B Mautner; Erik Ohman; L D Suárez; Paul W Armstrong; Kathy B Gates; Galen S Wagner
Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial).
The American journal of cardiology 2000;86(1):24-9.
2000: eric boersma; K S Pieper; E W Steyerberg; Robert G Wilcox; W C Chang; K L Lee; K Martijn Akkerhuis; Robert A Harrington; Jaap Deckers; Paul W Armstrong; A Michael Lincoff; Robert M Califf; Eric J Topol; Maarten L Simoons
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators.
Circulation 2000;101(22):2557-67.
2000: Robert M Califf; Karen S Pieper; K L Lee; Frans Van de Werf; R J Simes; Paul W Armstrong; Eric J Topol
Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial.
Circulation 2000;101(19):2231-8.
2000: Paul W Armstrong; Jeffrey R Burton; D Palisaitis; Christopher Thompson; Frans Van de Werf; B Rose; Désiré Collen; Koon K Teo
Collaborative angiographic patency trial of recombinant staphylokinase (CAPTORS).
American heart journal 2000;139(5):820-3.
2000: Dale Sholter; Paul W Armstrong
Adverse effects of corticosteroids on the cardiovascular system.
The Canadian journal of cardiology 2000;16(4):505-11.
1999: Erik Ohman; Paul W Armstrong; Harvey D White; Christopher B Granger; Robert G Wilcox; W Douglas Weaver; W Brian Gibler; Amanda L Stebbins; C Cianciolo; Robert M Califf; Eric J Topol
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries.
The American journal of cardiology 1999;84(11):1281-6.
1999: Paul W Armstrong
Unsticking platelets: the role of glycoprotein IIb/IIIa receptor blockade.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1999;161(11):1423-4.
1999: Wayne B Batchelor; eric peterson; Daniel B Mark; J David Knight; Christopher B Granger; Paul W Armstrong; Robert M Califf
A comparison of U.S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: efficiency, yield and long-term implications.
Journal of the American College of Cardiology 1999;34(1):12-9.
1999: Finlay A McAlister; Koon K Teo; M Taher; Terrence J Montague; Dennis P Humen; L Cheung; M Kiaii; R Yim; Paul W Armstrong
Insights into the contemporary epidemiology and outpatient management of congestive heart failure.
American heart journal 1999;138(1 Pt 1):87-94.
1999: J B Choy; Paul W Armstrong
Anticoagulant therapy in unstable angina.
Cardiology clinics 1999;17(2):327-43, ix.
1999: John H Alexander; Robert A Harrington; Robert H Tuttle; Lisa G Berdan; A Michael Lincoff; Jaap Deckers; Maarten L Simoons; AD Guerci; Judith S Hochman; Robert G Wilcox; Michael M Kitt; P R Eisenberg; Robert M Califf; Eric J Topol; K Karsh; W Ruzyllo; J Stepinska; P Widimsky; J B Boland; Paul W Armstrong
Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy.
The American journal of cardiology 1999;83(8):1147-51.
1999: M P Wong; Paul W Armstrong
Supraventricular tachycardia terminated by external mechanical stimulation: a case of "pothole conversion".
Pacing and clinical electrophysiology : PACE 1999;22(2):376-8.
1998: K P Alexander; eric peterson; Christopher B Granger; A C Casas; Frans Van de Werf; Paul W Armstrong; AD Guerci; Eric J Topol; Robert M Califf
Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes trial.
Journal of the American College of Cardiology 1998;32(7):2023-30.
1998: Fadi H Khadour; Darryl W O'Brien; Yuling Fu; Paul W Armstrong; Richard Schulz
Endothelial nitric oxide synthase increases in left atria of dogs with pacing-induced heart failure.
The American journal of physiology 1998;275(6 Pt 2):H1971-8.
1998: Paul W Armstrong; Yuling Fu; Wei-Ching Chang; Eric J Topol; Christopher B Granger; Amadeo Betriu; Frans Van de Werf; Kerry L Lee; Robert M Califf
Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators.
Circulation 1998;98(18):1860-8.
1998: L Kristin Newby; Robert H Christenson; Erik Ohman; Paul W Armstrong; T D Thompson; K L Lee; C W Hamm; H A Katus; C Cianciolo; Christopher B Granger; Eric J Topol; Robert M Califf
Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators.
Circulation 1998;98(18):1853-9.
1998: B K Metz; Harvey D White; Christopher B Granger; R J Simes; Paul W Armstrong; J Hirsh; V Fuster; C M MacAulay; Robert M Califf; Eric J Topol
Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators.
Journal of the American College of Cardiology 1998;31(7):1493-8.
1998: J Hochrein; F Sun; Karen S Pieper; Kerry L Lee; K B Gates; Paul W Armstrong; W Douglas Weaver; Shaun G Goodman; Eric J Topol; Robert M Califf; Christopher B Granger; Galen S Wagner
Higher T-wave amplitude associated with better prognosis in patients receiving thrombolytic therapy for acute myocardial infarction (a GUSTO-I substudy). Global Utilization of Streptokinase and Tissue plasminogen Activator for Occluded Coronary Arteries.
The American journal of cardiology 1998;81(9):1078-84.
1997: Wayne Tymchak; Paul W Armstrong
Spectrum of ischemic heart disease and the role of biochemical markers.
Clinics in laboratory medicine 1997;17(4):701-25.
1997: S Gill; S Majumdar; Neil E Brown; Paul W Armstrong
Ticlopidine-associated pancytopenia: implications of an acetylsalicylic acid alternative.
The Canadian journal of cardiology 1997;13(10):909-13.
1997: Fadi H Khadour; R H Kao; S Park; Paul W Armstrong; Bethany J Holycross; Richard Schulz
Age-dependent augmentation of cardiac endothelial NOS in a genetic rat model of heart failure.
The American journal of physiology 1997;273(3 Pt 2):H1223-30.
1997: Scott Darrell Berkowitz; Christopher B Granger; Karen S Pieper; Kerry L Lee; Joel M Gore; Maarten L Simoons; Paul W Armstrong; Eric J Topol; Robert M Califf
Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators.
Circulation 1997;95(11):2508-16.
1997: Paul W Armstrong; Monica Caverson; L Adams; M Taylor; PM Olley
Evaluation of the Heart and Stroke Foundation of Canada Research Scholarship Program: research productivity and impact.
The Canadian journal of cardiology 1997;13(5):507-16.
1997: T S Tsang; Robert M Califf; A L Stebbins; Kerry L Lee; S Cho; A M Ross; Paul W Armstrong
Incidence and impact on outcome of streptokinase allergy in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA in Occluded Coronary Arteries.
The American journal of cardiology 1997;79(9):1232-5.
1997: Eric J Topol; Robert M Califf; Frans Van de Werf; Maarten L Simoons; J Hampton; K L Lee; H White; R John Simes; Paul W Armstrong
Perspectives on large-scale cardiovascular clinical trials for the new millennium. The Virtual Coordinating Center for Global Collaborative Cardiovascular Research (VIGOUR) Group.
Circulation 1997;95(4):1072-82.
1997: SY Chan; G B Mancini; Yuling Fu; Darryl W O'Brien; Paul W Armstrong
Novel methodology for echocardiographic quantification of cardiac shape.
The Canadian journal of cardiology 1997;13(2):153-9.
1997: Yuling Fu; Darryl W O'Brien; SY Chan; Susan Kaufman; G W Moe; Paul W Armstrong
Does a hypertonic saline load predict fluid retention in pacing induced heart failure?
Cardiovascular research 1997;33(1):172-80.